Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cerium Pharmaceuticals logo — Rare people. Rare Medicines.

Cerium Pharmaceuticals

Rare people. Rare Medicines.

Founded 2012 4 employees Venture round Total: $13.08M Biotechnology, Health Care +2

General Information

Company Name Cerium Pharmaceuticals
Founded Year 2012
Employees 4
Industries Biotechnology, Health Care, Medical Devices +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Cerium Pharmaceuticals. To contact Cerium Pharmaceuticals, visit ceriumpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cerium Pharmaceuticals compare?

A PDF of Cerium Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cerium Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cerium Pharmaceuticals

Cerium Pharmaceuticals is a biotechnology startup focused on developing efficacious therapies for patients with kidney diseases. Founded in 2012, the company's current primary goal is to create the first drug approved for a rare kidney disease, Primary Membranous Nephropathy (PMN), which affects approximately 75,000 patients in the US, with approximately 3,000 new diagnoses annually. With its slogan "Rare people. Rare Medicines.", Cerium Pharmaceuticals is committed to addressing the unmet medical needs within the kidney disease space. The company recently secured an $8.90M Venture Round investment on 30 July 2021, demonstrating investor confidence in its mission and potential. This latest investment signifies external validation and financial support for Cerium's endeavors to develop groundbreaking therapies for kidney diseases.

Business keywords: Pharmaceuticals, Rare Diseases, Kidney Diseases, Drug Development, Primary Membranous Nephropathy, Therapies, Efficacy, Patient Care, Medical Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $8.90M -
30 Jul 2021
Debt Financing $1.91M -
25 May 2021
Venture Round $2.27M -
27 Jun 2016

Cerium Pharmaceuticals Alternatives & Competitors

View All Alternatives
Cerium Pharmaceuticals vs
Allena Pharmaceuticals, Inc.
Allena Pharmaceuticals, Inc. United States

Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney Disorders

Post-IPO Equity
13 employees
Biotechnology, Health and Wellness
Cerium Pharmaceuticals vs
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals United States

Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat rare and u...

IPO
12 employees
Cerium Pharmaceuticals vs
Intercept Pharmaceuticals
Intercept Pharmaceuticals United States

Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.

Post-IPO Debt
376 employees
Biotechnology, Health Care
View all alternatives

FAQ About Cerium Pharmaceuticals

Rare people. Rare Medicines.
Cerium Pharmaceuticals was founded in 2012.
Cerium Pharmaceuticals operates in Biotechnology, Health Care, Medical Devices and Pharmaceutical. Its work centres on Pharmaceuticals, Rare Diseases, Kidney Diseases and Drug Development.
Cerium Pharmaceuticals has approximately 4 employees.
Cerium Pharmaceuticals has completed 3 funding rounds, raising a total of $13.08M. The latest funding stage is Venture round.
Top alternatives and competitors to Cerium Pharmaceuticals include Allena Pharmaceuticals, Inc., Eloxx Pharmaceuticals, Intercept Pharmaceuticals, Santhera Pharmaceuticals, Newron Pharmaceuticals SpA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cerium Pharmaceuticals and Allena Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cerium Pharmaceuticals, https://bouncewatch.com/company/cerium-pharmaceuticals, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout